once weekly glp 1 agonist Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesity GLP-1 Receptor Agonist Market Size

Biochemistry 46:22752288 Hirst J, Carroll J, Fearnley IM, Shannon RJ, Walker JE (2003) The nuclear encoded subunits of complex I from bovine heart mitochondria

Future advancements in anticancer immunotherapy, with special reference to therapy based on anti-CTLA-4 inhibitors, will depend on the success of the use of a combination of target-specific anticancer drugs targeting various active immune regulatory pathways and thereby alter the immunological responses in the host, in a coordinated and synergistic manner

10.14218/JCTH.2015.00052 61 ZhangM.TangZ

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas